Back

B2M Antibody 0 Publications

Mouse Monoclonal| Catalog number: 66207-1-Ig |CloneNo.: 1C3B7

  • Print page
  • Download PDF

-_-

Freight/Packing

Con: 219 μg/150 μl

Choose size:

Please visit your regions distributor:

Request quote for
bulk/custom formulations

Special offer: Add control/tag antibody for $99
Load more
Tested Applications
Applications:
ELISA, WB, IHC
Application not tested? Please see our Guarantee


Images See all

66207-1-Ig;Raji cells

Raji cells were subjected to SDS PAGE followed by western blot with 66207-1-Ig( B2M Antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours

66207-1-Ig;human prostate cancer tissue

Immunohistochemistry of paraffin-embedded human prostate cancer tissue slide using 66207-1-Ig (B2M Antibody) at dilution of 1:200 (under 10x lens)

66207-1-Ig;human prostate cancer tissue

Immunohistochemistry of paraffin-embedded human prostate cancer tissue slide using 66207-1-Ig (B2M Antibody) at dilution of 1:200 (under 40x lens)

Species specificity:
human
Positive WB detected in:
Raji cells
Positive IHC detected in:
human prostate cancer tissue, human prostate cancer tissue, human renal cell carcinoma tissue
Recommended dilution:
WB : 1:1000-1:8000
IHC : 1:20-1:200

Product Information

Source:
Mouse
Purification method:
Protein A purification
Isotype:
IgG2b
Storage:
PBS with 0.02% sodium azide and 50% glycerol pH 7.3. Store at -20oC. Aliquoting is unnecessary for -20oC storage.

Immunogen Information

Immunogen:
Peptide
Full name:
beta-2-microglobulin
Calculated molecular weight:
14 kDa
Observed molecular weight:
13 kDa
GenBank accession number:
BC032589
Gene ID (NCBI):
567
Gene symbol
B2M
Synonyms
B2M, beta 2 microglobulin, HDCMA22P
Background

Beta-2-microglobulin (B2M) is a component of MHC class I molecules, which are present on the surface of nearly all nucleated cells. It can be found in body fluids under physiologic conditions as a result of shedding from cell surfaces or intracellular release. B2M has various biological functions, including antigen presentation. Investigations reveal that increased synthesis and release of B2M are present in several malignant diseases.


Back
to top